Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

3.

Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?

Giagulli VA, Giorgino R, Vermeulen A.

J Steroid Biochem Mol Biol. 1991 Jul;39(1):55-61.

PMID:
1829956
5.

Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A.

Vexiau P, Fiet J, Boudou P, Villette JM, Feutren G, Hardy N, Julien R, Dreux C, Bach JF, Cathelineau G.

J Steroid Biochem. 1990 Jan;35(1):133-7.

PMID:
2137888
6.
7.
8.

Physiopathology of plasma androstanediol-glucuronide.

Vermeulen A, Giagulli VA.

J Steroid Biochem Mol Biol. 1991 Nov;39(5B):829-33.

PMID:
1835405
9.

Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.

Montalto J, Funder JW, Yong AB, Whorwood CB, Connelly JF.

J Steroid Biochem Mol Biol. 1990 Nov 30;37(4):593-8.

PMID:
2177625
10.

Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.

Giagulli VA, De Pergola G, Giorgino F, Cignarelli M, Abbaticchio G, Vermeulen A, Giorgino R.

Clin Endocrinol (Oxf). 1992 Jun;36(6):553-8.

PMID:
1424180
11.

The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay.

Laband P, Tresguerres JA, Lisboa BP, Volkwein U, Tamm J.

Acta Endocrinol (Copenh). 1978 Aug;88(4):778-86.

PMID:
581118
12.

Serum androstanediol glucuronide in women with facial hirsutism.

Salman K, Spielvogel RL, Shulman LH, Miller JL, Vanderlinde RE, Rose LI.

J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):411-4.

PMID:
1564146
13.

Androstanediol glucuronide plasma clearance and production rates in normal and hirsute women.

Greep N, Hoopes M, Horton R.

J Clin Endocrinol Metab. 1986 Jan;62(1):22-7.

PMID:
3940268
15.

Serum 5-androstene-3 beta,17 beta-diol sulphate and 5 alpha-androstane-3 alpha,17 beta-diol sulphate in hirsute females with polycystic ovarian disease.

Montalto J, Funder JW, Yong AB, Davies HE, Connelly JF.

J Steroid Biochem. 1990 Jun;36(1-2):67-74.

PMID:
2362450
16.
17.

Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.

Kirschner MA, Samojlik E, Szmal E.

J Clin Endocrinol Metab. 1987 Oct;65(4):597-601.

PMID:
3654909
18.

Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.

Meczekalski B, Slopien R, Warenik-Szymankiewicz A.

Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):88-92. Epub 2006 Sep 18.

PMID:
16979812
19.

Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.

Miles RA, Cassidenti DL, Carmina E, Gentzschein E, Stanczyk FZ, Lobo RA.

Fertil Steril. 1992 Oct;58(4):708-12.

PMID:
1426314
20.

Is hirsutism an evolving syndrome?

Toscano V, Adamo MV, Caiola S, Foli S, Petrangeli E, Casilli D, Sciarra F.

J Endocrinol. 1983 Jun;97(3):379-87.

PMID:
6223108

Supplemental Content

Support Center